Myocyte enhancer factor 2C in hematopoiesis and leukemia

Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation inDrosophila

(2012) S K Pallavi et al.   EMBO JOURNAL

Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells

(2012) Sarah F. Andrews et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins

(2012) Irina Debnath et al.   INTERNATIONAL IMMUNOLOGY

Notch3 and Mef2c Proteins Are Mutually Antagonistic via Mkp1 Protein and miR-1/206 MicroRNAs in Differentiating Myoblasts

(2012) Jeffrey Gagan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia

(2012) S Agatheeswaran et al.   LEUKEMIA

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding

(2012) A Ptasinska et al.   LEUKEMIA

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

(2012) Jinghui Zhang et al.   NATURE

Refining the phenotype associated with MEF2C point mutations

(2012) Thierry Bienvenu et al.   NEUROGENETICS

In Vivo Analysis of MEF2 Transcription Factors in Synapse Regulation and Neuronal Survival

(2012) M. Waseem Akhtar et al.   PLoS One

Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders

(2011) Fady M. Mikhail et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia

(2011) Irene Homminga et al.   CANCER CELL

Functional Gene Expression Analysis of Tissue-Specific Isoforms of Mef2c

(2011) Yoshiharu Sekiyama et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10

(2011) P. Agarwal et al.   DEVELOPMENT

Mef2cdeletion in osteocytes results in increased bone mass

(2011) Ina Kramer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

ETV6mutations in early immature human T cell leukemias

(2011) Pieter Van Vlierberghe et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

(2011) Ryan D. Morin et al.   NATURE

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model

(2011) Eun-Gyung Cho et al.   PLoS One

Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia

(2010) Jules P.P. Meijerink   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Alternative splicing ofMef2cpromoted by Fox-1 during neural differentiation in P19 cells

(2010) Nor Hakimah Ab Hakim et al.   GENES TO CELLS

PC4/Tis7/IFRD1Stimulates Skeletal Muscle Regeneration and Is Involved in Myoblast Differentiation as a Regulator of MyoD and NF-κB

(2010) Laura Micheli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis

(2009) C. Gekas et al.   BLOOD

Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C

(2009) M. Schwieger et al.   BLOOD

Transcriptional Mechanisms by the Coregulator MAML1

(2009) M. Just Ribeiro et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes

(2009) Angela Nebbioso et al.   EMBO REPORTS

MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations

(2009) N. Le Meur et al.   JOURNAL OF MEDICAL GENETICS

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

(2009) Elaine Coustan-Smith et al.   LANCET ONCOLOGY

Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c

(2009) Sandra Stehling-Sun et al.   NATURE IMMUNOLOGY

HOXA9 is required for survival in human MLL-rearranged acute leukemias

(2008) J. Faber et al.   BLOOD

The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate

(2008) A. Schuler et al.   BLOOD

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia

(2008) P. Van Vlierberghe et al.   BLOOD

Cooperative interaction ofNkx2.5andMef2ctranscription factors during heart development

(2008) Joshua W. Vincentz et al.   DEVELOPMENTAL DYNAMICS

Myocyte Enhancer Factor 2C as a Neurogenic and Antiapoptotic Transcription Factor in Murine Embryonic Stem Cells

(2008) Z. Li et al.   JOURNAL OF NEUROSCIENCE

Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C

(2008) Zhen-Xing Ji et al.   MOLECULAR GENETICS AND GENOMICS

Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

(2008) Jonathan B. Johnnidis et al.   NATURE

Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation

(2008) Peter R Wilker et al.   NATURE IMMUNOLOGY

Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways

(2008) A S McElhinny et al.   ONCOGENE

Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo

(2008) H. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function

(2008) A. C. Barbosa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A p38 MAPK-MEF2C pathway regulates B-cell proliferation

(2008) D. Khiem et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination

(2008) Ellen V. Rothenberg et al.   SEMINARS IN IMMUNOLOGY